(Total Views: 85)
Posted On: 01/09/2017 9:11:52 AM
Post# of 22868
$PTN: .61 1.6M volume .61 x .615 new... AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekynda™ (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
https://finance.yahoo.com/news/amag-pharmaceu...00216.html
https://finance.yahoo.com/news/amag-pharmaceu...00216.html
(1)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
Scroll down for more posts ▼
